Clarke C J, Trapani J A, Johnstone R W
Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, Victoria 3002, Australia.
Curr Drug Targets Immune Endocr Metabol Disord. 2001 Aug;1(2):117-30.
Interferons (IFNs) are an important part of immune responses and are believed to protect the host from viral and bacterial pathogens as well as having a role in rejection of malignancies. The well-known anti-viral and cytostatic properties of IFNs have led to the clinical use of these proteins to treat some cancers and viral infections. Extensive research has begun to unravel much of the molecular basis for the biological effects of IFNs, and this information could now be used as a foundation for the development of novel therapeutic strategies that avoid some of the acknowledged shortcomings of cytokine therapies. This review explains the current model of IFN action, during viral infections and the potential for well-established and emerging groups of IFN inducible genes as therapeutic targets is highlighted.
干扰素(IFNs)是免疫反应的重要组成部分,被认为可保护宿主免受病毒和细菌病原体侵害,并且在恶性肿瘤的排斥反应中发挥作用。干扰素众所周知的抗病毒和细胞抑制特性已使其在临床上用于治疗某些癌症和病毒感染。广泛的研究已开始揭示干扰素生物学效应的许多分子基础,这些信息现在可作为开发新型治疗策略的基础,以避免细胞因子疗法的一些公认缺点。本综述解释了病毒感染期间干扰素作用的当前模型,并强调了成熟的和新兴的干扰素诱导基因群体作为治疗靶点的潜力。